ArticleFrontiers in immunology2022

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Yi-Ling Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.